Login

Switch On Your HIV Smarts.

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

, by Liz Highleyman

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More

Research will see if antibodies can more selectively target & kill HIV-infected cells

Research will see if antibodies can more selectively target & kill HIV-infected cells

, by Emily Newman

In this Q&A, Galit Alter, PhD explains her research on broadly functional antibodies and if they can be used to rid the body of the latent HIV reservoir. Read More

Medicaid, the biggest HIV insurance provider, is seriously vulnerable under President Trump’s administration

Medicaid, the biggest HIV insurance provider, is seriously vulnerable under President Trump’s administration

, by Emily Newman

Block granting Medicaid will lead to funding cuts, say experts, which will impact people living with HIV and many others. Read More

New legislation would replace “outdated” and “dangerous” HIV criminalization laws

New legislation would replace “outdated” and “dangerous” HIV criminalization laws

, by Emily Newman

California Senator Scott Wiener and collaborators have introduced new legislation in an attempt to overhaul HIV criminalization laws from the late 1980s. Read More

New research shows abnormal immune activation even in very early HIV infection

New research shows abnormal immune activation even in very early HIV infection

, by Emily Newman

Findings may help explain why early ART may improve, but fail to fully restore, health and life expectancies of people living with HIV on therapy. Read More